Latest News

In honor of ALS Awareness Month, the team and supporters of the ALS Center of Excellence shared their takes on the impact of amyotrophic lateral sclerosis (ALS).

The Michigan Medicine blog covered research published by Frances and Kenneth Eisenberg Emerging Scholar Kevin Chen, M.D., found that stem cells improved some memory and reduced inflammation when injected into a preclinical Alzheimer's disease model.

Eva Feldman, M.D., Ph.D., James W. Albers Distinguished University Professor of Neurology, was part of a research group that published insights into the role gender plays in the everyday experiences of women clinician scientists and the related barriers they face.

Featured on the cover and in a subsequent story of the American Academy of Neurology's Neurology Today , Dr. Eva Feldman explored the environmental triggers of neurodegenerative disease.

The University of Michigan's independent, student-run newspaper covered the latest research happening at the ALS Center of Excellence.

Kevin Chen M.D., and Stephanie Eid, Ph.D., have been named the inaugural Frances and Kenneth Eisenberg Emerging Scholars at the NeuroNetwork for Emerging Therapies.

Brian Callaghan, M.D., M.S., authored research published in Neurology , the official journal of the American Academy of Neurology, that answered just that.

Pranger ALS Clinic Director Stephen Goutman, M.D., M.S., was interviewed by the Canadian media organization about this recent publication on ALS recreational risk.

In the journal Academic Medicine, Eva Feldman, M.D., Ph.D., was an author of the study “The Disproportionate Effects of the COVID-19 Pandemic on the Time Allocation of Recipients of NIH Career Development Awards Who Are Women or Caregivers of Dependents.”